Search Results - John D Davis

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Semi‐Mechanistic Population Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Dupilumab on Pre‐Bronchodilator Forced Expiratory Volume in 1 Second (FEV1) in Uncontrolled Moderate... by Li Zhang, John D. Davis, Vanaja Kanamaluru, Christine Xu

    Get full text
    Article


  2. 2

    CD20×CD3 Bispecific Antibodies in B‐NHL: A Review of Translational Science, Pharmacokinetics, Pharmacodynamics, and Dose Strategy in Clinical Research by Min Zhu, Xiaowen Guan, Samit Ganguly, Erik Welf, John D. Davis

    Published in Clinical and Translational Science (2025-06-01)
    Get full text
    Article


  3. 3

    Dupilumab: Mechanism of action, clinical, and translational science by Marc R. McCann, Matthew P. Kosloski, Christine Xu, John D. Davis, Mohamed A. Kamal

    Published in Clinical and Translational Science (2024-08-01)
    Get full text
    Article


  4. 4

    Population pharmacokinetics modeling and exposure‐response analyses of cemiplimab in patients with recurrent or metastatic cervical cancer by Jenny‐Hoa Nguyen, Daniel Epling, Nancy Dolphin, Anne Paccaly, Daniela Conrado, John D. Davis, Nidal Al‐Huniti

    Get full text
    Article


  5. 5

    Pharmacokinetics and pharmacodynamics of mibavademab (a leptin receptor agonist): Results from a first‐in‐human phase I study by Andrew Gewitz, Jeanne Mendell, Yuhuan Wang, Charles Harris, Benjamin A. Olenchock, Simona Podgrabinska, Wenjun Zheng, An Zhao, Hao Pan, Frédéric Vanhoutte, John D. Davis

    Published in Clinical and Translational Science (2024-04-01)
    Get full text
    Article


  6. 6

    Translational findings support regimen selection for first‐in‐human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer by Min Zhu, Priyanka Madia, Alison Crawford, Jurriaan Brouwer‐Visser, Pamela Krueger, Lauric Haber, Mary Peterman, Thomas S. Uldrick, Elizabeth Miller, John D. Davis, Marc W. Retter

    Published in Clinical and Translational Science (2024-12-01)
    Get full text
    Article


  7. 7

    A drug‐disease model for predicting survival in an Ebola outbreak by Masood Khaksar Toroghi, Nidal Al‐Huniti, John D. Davis, A. Thomas DiCioccio, Ronda Rippley, Alina Baum, Christos A. Kyratsous, Sumathi Sivapalasingam, Joel Kantrowitz, Mohamed A. Kamal

    Published in Clinical and Translational Science (2022-10-01)
    Get full text
    Article


  8. 8

    Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate‐to‐severe atopic dermatitis: Results from two terminated phase II trials by Matthew P. Kosloski, Emma Guttman‐Yassky, Michael J. Cork, Margitta Worm, Dong‐Ho Nahm, Xiaoping Zhu, Marcella K. Ruddy, Sivan Harel, Mohamed A. Kamal, Hélène Goulaouic, Christine R. Xu, Elena Avetisova, John D. Davis, Michael C. Nivens, Arsalan Shabbir, Allen Radin

    Published in Clinical and Translational Science (2024-08-01)
    Get full text
    Article


  9. 9

    A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip by Stephen J. DiMartino, Jingning Mei, Thomas J. Schnitzer, Haitao Gao, Simon Eng, Christine Winslow, Tina Ho, Kenneth C. Turner, Hazem E. Hassan, Yamini Patel, John D. Davis, Ngan Trinh, Angela Manley, Garen Manvelian, Michael Fetell, Ned Braunstein, Gregory P. Geba, Paula Dakin

    Published in Osteoarthritis and Cartilage Open (2024-12-01)
    Get full text
    Article


  10. 10

    GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial by Dinko Gonzalez Trotter, Stephen Donahue, Chris Wynne, Shazia Ali, Prodromos Parasoglou, Anita Boyapati, Kusha Mohammadi, Bret J. Musser, Pretty Meier, Jason Mastaitis, Mark W. Sleeman, David J. Glass, Evelyn Gasparino, Jesus Trejos, John D. Davis, Boaz Hirshberg, Robert Pordy, George D. Yancopoulos, Gary A. Herman

    Published in Nature Communications (2025-05-01)
    Get full text
    Article


  11. 11

    Efficacy and safety of fasinumab in an NSAID-controlled study in patients with pain due to osteoarthritis of the knee or hip by Stephen J. DiMartino, Haitao Gao, Simon Eng, Guillermo Valenzuela, Thomas Fuerst, Chetachi Emeremni, Tina Ho, Hazem E. Hassan, Kenneth C. Turner, John D. Davis, Souhil Zaim, Jesse Chao, Yamini Patel, Lillian Brener, Ngan Trinh, Garen Manvelian, Michael Fetell, Ned Braunstein, Gregory P. Geba, Paula Dakin

    Published in BMC Musculoskeletal Disorders (2025-02-01)
    Get full text
    Article


  12. 12

    Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis by Mohamed A. Kamal, Matthew P. Kosloski, Ching-Ha Lai, Michael A. Partridge, Manoj Rajadhyaksha, Vanaja Kanamaluru, Ashish Bansal, Arsalan Shabbir, Brad Shumel, Marius Ardeleanu, Susan M. Richards, Hong Yan, Christine R. Xu, Ainara Rodríguez-Marco, Jing Xiao, Faisal A. Khokhar, Guy Gherardi, Elisa Babilonia, Jennifer Maloney, Eric Mortensen, Bolanle Akinlade, Ned Braunstein, Neil Stahl, Albert Torri, John D. Davis, A. Thomas DiCioccio

    Published in Frontiers in Immunology (2024-11-01)
    Get full text
    Article


  13. 13

    Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomise... by Jing Xiao, Paula Dakin, Gregory P Geba, Edward Cox, Rafia Bhore, Jennifer D Hamilton, Shazia Ali, Yogesh Patel, Thomas D Norton, Mazhar Thakur, Samit Ganguly, Jesse Chao, Alpana Waldron, Kenneth C Turner, John D Davis, Susan C Irvin, Cynthia Pan, Dominique Atmodjo-Watkins, Andrea T Hooper, Danise Subramaniam, Joseph A Bocchini, Bari Kowal, A. Thomas DiCioccio, Ned Braunstein, Gary A Herman

    Published in BMJ Open (2024-10-01)
    Get full text
    Article


Search Tools: